Dr. Alexander Dimitrios Colevas MD

Fellowships

• Dana Farber Cancer Institute   1995

Publications

• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKHead and Neck Cancers, Version 2.2013 Featured Updates to the NCCN Guidelines2013
• American jourl of clinical oncologyStereotactic radiosurgery for retreatment of gross perineural invasion2013
• Jourl of clinical oncology : official jourl of the American Society ofBiased View of the Role of Site-Specific Therapy in Carcinoma of Unknown Primary.0
• INVESTIGATIOL NEW DRUGSPhase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 32012
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSTumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors2012
• BRITISH JOURL OF CANCERA phase I dose-escalation study of aflibercept administered in combition with pemetrexed2012
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSValidation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer2012
• CANCER CHEMOTHERAPY AND PHARMACOLOGYPhase I trial of the combition of flavopiridol and imatinib mesylate in patients with Bcr-Abl2012
• Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., ScheerEffect of stimulation of tural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab0
• Wiegner, E. A., Daly, M. E., Murphy, J. D., Abelson, J., Chapman, C. HIntensity-Modulated Radiotherapy for Tumors of the sal Cavity and Parasal Sinuses2012
• CANCER INVESTIGATIONMaintence Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced2012
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKMucosal Melanoma of the Head and Neck2012
• JOURL OF CLINICAL INVESTIGATIONStimulation of tural killer cells with a CD1372012
• LANCET ONCOLOGYAddition of bevacizumab to st2012
• Chemotherapy research and practiceThe use of epidermal growth factor receptor monoclol antibodies2012
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKHead and Neck Cancers2011
• JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKControversies in the Locoregiol Magement of Head and Neck Cancer2011
• HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NINTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX2011
• JOURL OF THORACIC ONCOLOGYA Phase II First-Line Study of Gemcitabine, Carboplatin2010
• HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NHIGHER INCIDENCE OF HEAD AND NECK CANCERS AMONG VIETMESE AMERICAN MEN IN CALIFORNIA2010
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSMOLECULAR AND CLINICAL RESPONSES IN A PILOT STUDY OF GEFITINIB WITH PACLITAXEL AND RADIATION IN2010
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSLONG-TERM OUTCOMES AND TOXICITY OF CONCURRENT PACLITAXEL AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD2009
• Eastham, D. V., Chapman, C. H., Rao, A. K., rasimhan, B., Quon, A., VaDoes Pre-treatment Metabolic Tumor Growth Rate (MTGR) Predict Progression in Lung Cancer?2009
• BRITISH JOURL OF HAEMATOLOGYA multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone2008
• Jourl of the tiol Comprehensive Cancer NetworkHead and neck cancers.2008
• INVESTIGATIOL NEW DRUGSPhase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck2008
• JOURL OF CLINICAL ONCOLOGYPatient-reported outcomes and the evolution of adverse event reporting in oncology2007
• NEW ENGLAND JOURL OF MEDICINECisplatin and fluorouracil alone or with docetaxel in head and neck cancer2007
• INVESTIGATIOL NEW DRUGSA phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors2007
• JOURL OF CLINICAL ONCOLOGYPhase I and correlative biology study of cilengitide in patients with recurrent malignt glioma2007
• CANCER BIOLOGY & THERAPYA phase II study of ixabepilone (BMS-247550) in metastatic rel-cell carcinoma2007
• EUROPEAN JOURL OF CANCERPhase I study of continuous weekly dosing of dimethylamino benzoylphenylurea2007
• JOURL OF CLINICAL ONCOLOGYAdverse event reporting in publications compared with sponsor database for cancer clinical trials2006
• JOURL OF CLINICAL ONCOLOGYChemotherapy options for patients with met2006
• CLINICAL GENITOURIRY CANCERPhase II evaluations of cilengitide in asymptomatic patients with2006
• JOURL OF CLINICAL ONCOLOGYIxabepilone (epothilone B alogue BMS2005
• CANCERPhase I trial and pharmacokinetics of escalating doses of paclitaxel2005
• JOURL OF CLINICAL ONCOLOGYMulti-institutiol randomized phase II trial of the epothilone B alog ixabepilone2005
• INVESTIGATIOL NEW DRUGSPhase II trial of flavopiridol, a cyclin dependent kise inhibitor2004
• SEMIRS IN RADIATION ONCOLOGYCTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer2003
• JOURL OF THE TIOL CANCER INSTITUTEDevelopment of investigatiol radiation modifiers2003
• AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALSPhase I/II trial of outpatient docetaxel2002
• INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHypothyroidism incidence after multimodality treatment for stage III2001
• ONCOLOGY-NEW YORKClinical trials referral resource: Current clinical trials of epothilone B alog (BMS-247550)2001
• JOURL OF CLINICAL ONCOLOGYMulticenter phase I-II trial of docetaxel, cisplatin2001
• SEMIRS IN ONCOLOGYThe role of induction chemotherapy in the curative treatment of squamous cell cancer of the head2000
• ANLS OF ONCOLOGYA phase II trial of palliative docetaxel plus 5-fluorouracil for squamous2000
• JOURL OF CLINICAL ONCOLOGYPhase II trial of docetaxel, cisplatin1999
• OTOLARYNGOLOGY-HEAD AND NECK SURGERYIntramucosal spread of malignt melanoma of the oral cavity1998
• AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALSDocetaxel in head and neck cancer - A review1998
• JOURL OF CLINICAL ONCOLOGYInduction chemotherapy with docetaxel, cisplatin1998
• LARYNGOSCOPELong-Term Outcomes of Surgery Followed by Radiation Therapy for Minor Salivary Gland Carcinomas2013
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKHead and Neck Cancers, Version 2.2013 Featured Updates to the NCCN Guidelines2013
• American journal of clinical oncologyStereotactic radiosurgery for retreatment of gross perineural invasion2013
• CANCERImpact of positron emission tomography2013
• Journal of clinical oncology : official journal of the American SocietBiased View of the Role of Site-Specific Therapy in Carcinoma of Unknown Primary.0
• Head & neckPopulation-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic0
• CANCER CHEMOTHERAPY AND PHARMACOLOGYCo-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with2013
• INVESTIGATIONAL NEW DRUGSPhase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 32012
• GYNECOLOGIC ONCOLOGYA Phase 2 Trial of Flavopiridol2012
• INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSTumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors2012
• BRITISH JOURNAL OF CANCERA phase I dose-escalation study of aflibercept administered in combination with pemetrexed2012
• INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSValidation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer2012
• MELANOMA RESEARCHA randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma2012
• CANCER CHEMOTHERAPY AND PHARMACOLOGYPhase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl2012
• Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., ScheerEffect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab0
• Wiegner, E. A., Daly, M. E., Murphy, J. D., Abelson, J., Chapman, C. HIntensity-Modulated Radiotherapy for Tumors of the Nasal Cavity and Paranasal Sinuses2012
• CANCER CHEMOTHERAPY AND PHARMACOLOGYA phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with2012
• CANCER INVESTIGATIONMaintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced2012
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKMucosal Melanoma of the Head and Neck2012
• JOURNAL OF CLINICAL INVESTIGATIONStimulation of natural killer cells with a CD1372012
• LANCET ONCOLOGYAddition of bevacizumab to st2012
• Chemotherapy research and practiceThe use of epidermal growth factor receptor monoclonal antibodies2012
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKHead and Neck Cancers2011
• JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKControversies in the Locoregional Management of Head and Neck Cancer2011
• HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD ANDINTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX2011
• JOURNAL OF THORACIC ONCOLOGYA Phase II First-Line Study of Gemcitabine, Carboplatin2010
• HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD ANDHIGHER INCIDENCE OF HEAD AND NECK CANCERS AMONG VIETNAMESE AMERICAN MEN IN CALIFORNIA2010
• INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSMOLECULAR AND CLINICAL RESPONSES IN A PILOT STUDY OF GEFITINIB WITH PACLITAXEL AND RADIATION IN2010
• Chang, C. N., Zhou, L. Y., MacFarlane, G., Tran, P., Rao, A., Chapman,Excellent early local control with tumor volume adapted dosing of stereotactic body radiation2009
• INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSLONG-TERM OUTCOMES AND TOXICITY OF CONCURRENT PACLITAXEL AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD2009
• Eastham, D. V., Chapman, C. H., Rao, A. K., Narasimhan, B., Quon, A., Does Pre-treatment Metabolic Tumor Growth Rate (MTGR) Predict Progression in Lung Cancer?2009
• BRITISH JOURNAL OF HAEMATOLOGYA multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone2008
• Journal of the National Comprehensive Cancer NetworkHead and neck cancers.2008
• INVESTIGATIONAL NEW DRUGSPhase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck2008
• JOURNAL OF CLINICAL ONCOLOGYPatient-reported outcomes and the evolution of adverse event reporting in oncology2007
• NEW ENGLAND JOURNAL OF MEDICINECisplatin and fluorouracil alone or with docetaxel in head and neck cancer2007
• INVESTIGATIONAL NEW DRUGSA phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors2007
• CLINICAL CANCER RESEARCHSequential flavopiridol, cytosine arabinoside2007
• CLINICAL CANCER RESEARCHInhibition of poly (ADP2007
• JOURNAL OF CLINICAL ONCOLOGYPhase I and correlative biology study of cilengitide in patients with recurrent malignant glioma2007
• CANCER BIOLOGY & THERAPYA phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma2007
• BLOODFlavopiridol administered using a pharmacologically derived schedule is2007
• EUROPEAN JOURNAL OF CANCERPhase I study of continuous weekly dosing of dimethylamino benzoylphenylurea2007
• JOURNAL OF CLINICAL ONCOLOGYAdverse event reporting in publications compared with sponsor database for cancer clinical trials2006
• JOURNAL OF CLINICAL ONCOLOGYChemotherapy options for patients with met2006
• CLINICAL GENITOURINARY CANCERPhase II evaluations of cilengitide in asymptomatic patients with2006
• CLINICAL CANCER RESEARCHIn vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea2005
• CLINICAL CANCER RESEARCHPhase I and pharmacokinetic study of flavopiridol followed by 1-beta2005
• JOURNAL OF CLINICAL ONCOLOGYIxabepilone (epothilone B analogue BMS2005
• CANCERPhase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent2005
• JOURNAL OF CLINICAL ONCOLOGYMulti-institutional randomized phase II trial of the epothilone B analog ixabepilone2005
• ONCOLOGY-NEW YORKCurrent clinical trials of cilengitide2004
• INVESTIGATIONAL NEW DRUGSPhase II trial of flavopiridol, a cyclin dependent kinase inhibitor2004
• CLINICAL CANCER RESEARCHHER2 expression in salivary gland carcinomas: Dependence on histological subtype2004
• ORAL ONCOLOGYHerceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study2003
• SEMINARS IN RADIATION ONCOLOGYCTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer2003
• JOURNAL OF THE NATIONAL CANCER INSTITUTEDevelopment of investigational radiation modifiers2003
• CANCERDocetaxel, cisplatin2003
• Cancer treatment and researchOrgan preservation-induction chemotherapy.2003
• CLINICAL CANCER RESEARCHTimed sequential therapy of acute leukemia with flavopiridol2003
• CANCERA Phase I/II trial of concurrent docetaxel and radiation2002
• AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALSPhase I/II trial of outpatient docetaxel2002
• INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHypothyroidism incidence after multimodality treatment for stage III2001
• ONCOLOGY-NEW YORKClinical trials referral resource: Current clinical trials of epothilone B analog (BMS-247550)2001
• Colevas, A. D., Amrein, P. C., Gomolin, H., Barton, J. J., Read, R. R.A Phase II study of combined oral uracil2001
• JOURNAL OF CLINICAL ONCOLOGYMulticenter phase I-II trial of docetaxel, cisplatin2001
• ONCOLOGY-NEW YORKNCCN Practice Guidelines for head and neck cancers2000
• SEMINARS IN ONCOLOGYThe role of induction chemotherapy in the curative treatment of squamous cell cancer of the head2000
• ANNALS OF ONCOLOGYA phase II trial of palliative docetaxel plus 5-fluorouracil for squamous2000
• JOURNAL OF CLINICAL ONCOLOGYPhase II trial of docetaxel, cisplatin1999
• Head & neckRe: Sialadenosis: a presenting sign in Bulemia (Head and Neck 20: 758-762, 1998)1999
• Tishler, R. B., Busse, P. M., Norris, C. M., Rossi, R., Poulin, M., ThAn initial experience using concurrent paclitaxel and radiation1999
• OTOLARYNGOLOGY-HEAD AND NECK SURGERYIntramucosal spread of malignant melanoma of the oral cavity1998
• AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALSDocetaxel in head and neck cancer - A review1998
• JOURNAL OF CLINICAL ONCOLOGYInduction chemotherapy with docetaxel, cisplatin1998
• The oncologistThe Prognostic Value of Thymidylate Synthase1998
• Oncology (Williston Park, N.Y.)Future directions in the treatment of squamous cell carcinoma of the head and neck1997

Experience & Accolades

• Associate Professor of Medicine (Oncology) and, by courtesy, of Otolarthe Stanford University Medical Center

Dr. Alexander Dimitrios Colevas MD's Practice location